Abstract:Objective To evaluate the early diagnostic value of matrix metalloproteinase-9 ( MMP-9) level on admission for ST-segment elevation myocardial infarction (STEMI),explore the relationship between MMP-9 and global registry of acute coronary events (GRACE) scores and determine the values of MMP-9 in short-term prognosis of STEMI.Methods A total of 55 STEMI patients admitted into our hospital between September 2011 and February 2012 were recruited.There were early STEMI ( ≤4h of onset,n =22) and late STEMI ( ＞ 4 h after onset,n =33).Fifty subjects of coronary artery without significant stenosis after angiography were enrolled into a control group.The plasma levels of MMP-9 in venous blood were detected with enzyme-linked immunosorbent assay (ELISA).And the GRACE risk score was used for risk assessment.The incidence of new or recurrent myocardial infarction,target vessel revascularization,cardiac death,heart failure (MACE) was recorded during a follow-up period of 6 months.Results The MMP-9 levels were significantly higher in patients with STEMI ( P ＜ 0.001 ),early STEMI ( P ＜ 0.001 ) and late STEMI (P ＜ 0.001 ) than the control group.And no statistical differences existed between early STEMI and late STEMI ( P ＞ 0.05 ).The level of MMP-9 was positively correlated with the GRACE risk score.MACE occurred in 8 [14.5％ (8/55)] patients during hospitalization and 17 [30.9％ ( 17/55 )] patients during follow-up.Receiver operating characteristic (ROC) curve analysis showed area under the curve (AUC) of on admission GRACE risk score and MMP-9 levels were 0.848 (95％ CI O.706-0.991,P =0.002) and 0.766 (95％ CI 0.575-0.957,P =0.017) respectively.ROC curve analysis showed AUC of hospital discharge GRACE risk score and MMP-9 levels were 0.737 (95％ CI 0.601-0.873,P =0.005 )and 0.711 (95％ CI 0.565-0.856,P =0.013 ) respectively.No statistical differences existed between GRACE risk score and MMP-9 levels for predicting the short-term risk of MACE (P ＞ 0.05 ).Conclusion The plasma level of MMP-9 has a higher diagnostic value for early STEMI.Positively correlated with the GRACE risk score,it is a predicator of short-term risk of MACE.

Value of MMP-9 in diagnosis and outcome evaluation of ACS patients

The clinic relevance between acute coronary syndrome and the level of serum matrix metalloproteinase-9

Value of Matrix Metalloproteinase - 9 and Ischemia - Modified Albumin for Diagnosis of Coronary Heart Disease

Relationship Between Matrix Metalloproteinase-9 and Tissue Metalloproteinase Inhibitor-1 and Carotid Atheromatous Plaque Stability

Clinical significance of serum interleukin-18 (IL-18) and matrix metalloproteinase-(MMP-9) on acute coronary syndrome

[Plasma Matrix Metalloproteinases-2 and -9 Levels Are Elevated in Patients with Acute Coronary Syndrome and Coronary Chronic Total Occlusion].

The Role of Serum High Sensitive C-reactive Protein and Matrix Metalloproteinase-9 in Risk Stratification of Patients with Acute Coronary Syndrome

Plasma Level of Matrix Metalloproteinase-9 in Patients with Acute Coronary Syndrome and Its Percutaneous Coronary Intervention

The Study of the Relation Between C-reactive Protein,fibrinogen and Acute Coronary Syndrome

Clinical Value of Combined Assay of Serumal Matrix Metalloproteinases-9 and C-reactive Protein in Patients with Coronary Artery Disease

Changes and Implication of Peripheral Blood Levels of Matrix Metalloproteases-9 and C-reactive Protein in Patients with Coronary Artery Disease

Values of matrix metalloproteinase-9 in early diagnosis and short-term prognosis of ST-segment elevation myocardial infarction

Clinical Significance of Plasma High Sensitive C-reactive Protein and Matrix Metalloproteinase-9 in Acute Myocardial Infarction

Combined Use of Matrix Metalloproteinase-9 and N-terminal Pro-Brain Natriuretic Peptide in Risk Stratification of Non-St Elevation Acute Coronary Syndrome

The clinical role of increase of serum matrix metalioproteinase-8 concentration in patients with acute coronary syndrome

Relationship between the plasma level of matrix metalloproteinase-9 and structural characteristics of plaques and percutaneous coronary intervention

N-Terminal Probrain Natriuretic Peptide and Matrix MetaIloproteinase-9 in Early Ventricular Remodeling of Non-ST Elevation Acute Coronary Syndrome

Continuous Observation and Implication of MMP-9 in Peripheral Blood in Patients with Acute Coronary Syndromes after PCI

Relationship of Serum Matrix Metalloproteinase-9 Level and Lipid Profiles in Coronary Heart Disease

Plasma Levels of Matrix Metalloproteinase-2 and Tissue Inhibitor of Matrix Metalloproteinase-2 and Its Relationship with Acute Coronary Syndrome

Significance of the Detection of Serum Levels of Matrix Metalloproteinases -1,-2,-3 and -9 in Thoracic Aortic Diseases and Acute Myocardial Ischemia